Clinical Trials Browser

Phase 2/3 × HMPL-013 × 1 year × Clear all

NCT06441565 2025-07-30

Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer

Phase 2/3 Recruiting

Gastrointestinal

Colorectal Neoplasms